ClinicalTrials.govpublic full text
Predictive Role of Circulating Angiogenic Factors for Second-line Paclitaxel and Ramucirumab.
gastric cancer stage iv, ramucirumab, gastric cancer, paclitaxel, predictive factors, vegf, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 869113
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.